Indaptus Therapeutics, Inc. (INDP) vs Palisade Bio, Inc. (PALI)
A side-by-side comparison of Indaptus Therapeutics, Inc. and Palisade Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INDP
Indaptus Therapeutics, Inc.
$2.57HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
PALI
Palisade Bio, Inc.
$1.51HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
Total return — INDP vs PALI
growth of $100 · dividends reinvested · last 10yINDP -100.0% (-57.2%/yr)PALI -100.0% (-71.2%/yr)INDP compounded faster over this window
Log scale — wide-divergence pair
INDP PALI
INDP vs PALI: by the numbers
- •INDP is the larger company ($291M vs $262M market cap).
- •Both run net losses; INDP's is the smaller (0.00% vs -6388.20% net margin).
Metrics side by side
Valuation
| Metric | INDP | PALI |
|---|---|---|
| P/S ratio | N/A | 524.07 |
| P/B ratio | 25.59 | 2.15 |
Profitability
| Metric | INDP | PALI |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | -6388.20% |
| ROE | -135.62% | -26.24% |
| ROIC | -129.90% | -28.96% |
Growth (annualized)
| Metric | INDP | PALI |
|---|---|---|
| Total return CAGR (5Y) | -58.32% | -76.02% |
Frequently asked
- How have INDP and PALI total returns compared?
- Over the past 10 years, INDP delivered -57.48% and PALI delivered -71.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.